When skincare backfires: The microbiome-stress-allergy axis in cosmetic hypersensitivity

Globally, the number of hypersensitivity reactions has increased with the usage of cosmetics, which mostly manifest as allergic or irritant contact dermatitis. This pathologic triad, now referred to as the microbiome-stress-allergy axis, is caused by the complex interactions of the skin microbiota, psychological stress, and immunological systems. Cosmetic contact allergy is prevalent globally, with lower positive patch test rates in European populations than those from the US, Asia, and the Middle East. Women are more susceptible due to exposure to allergens in cosmetics and household products. Incidence rates are higher in urban populations due to occupational and environmental factors. Certain occupations, such as healthcare professionals, hairdressers, and food handlers, are at particular risk of cosmetic-related hypersensitivity due to frequent exposure to soaps, disinfectants, hair dyes, and cosmetic chemicals, which compromise the skin barrier and increase allergen sensitization. This narrative review examines how the presence of allergens and preservatives in cosmetics can alter the skin barrier integrity and microbiome, making people more prone to inflammation and sensitization. In addition, it has been shown that psychological stress weakens skin immunity through cortisol and neuropeptide-based hormonal cascades, exacerbating skin disorders such as psoriasis, atopic dermatitis (AD), and acne. With an emphasis on mast cell function, T-cell imbalances, and compromised barriers, the review highlights recent research on immunological dysregulation caused by alteration of the microbiota and neuroendocrine variables. Clinical signs are discussed, such as urticaria, typical eczematous responses, and pigmentation diseases like Riehl melanosis. Populations at increased risk include women, healthcare professionals, those with an atopic background, and those who regularly use intricate skincare routines. Management strategies include using targeted patch testing to prevent allergies, probiotic or ceramide-based skincare products to rebuild the barrier, and psychodermatologic treatments to reduce stress. Adjunct pharmacologic therapy, including topical corticosteroids, calcineurin inhibitors, Janus kinase inhibitors, and phosphodiesterase-4 inhibitors, has shown efficacy in treating AD. Advances in microbiome profiling methods, such as metagenomic shotgun sequencing and amplicon-based sequencing, which are useful in profiling the skin microbiota, are spurring demand for personalized skincare. Artificial intelligence algorithms can predict component sensitivity to enhance tailored skincare by analyzing chemical compositions and comparing them with individual skin and allergy profiles. By integrating dermatological, immunological, and psychological knowledge, this review provides a thorough framework for understanding and managing cosmetic hypersensitivity in the modern era.